Allergy Therapeutics (AGY)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

10.00p
   
  • Change Today:
    -0.85p
  • 52 Week High: 12.10
  • 52 Week Low: 6.60
  • Currency: UK Pounds
  • Shares Issued: 6,332m
  • Volume: 255,046
  • Market Cap: £633.25m
  • RiskGrade: 268
  • Beta: 0.00

Regulatory News

Interim Results for six months ended 31 Dec 2025 31-Mar-2026 07:00 RNS
PDMR Dealings & Shareholding Update 12-Mar-2026 07:00 RNS
PDMR Dealings & Shareholding Update 12-Mar-2026 07:00 RNS
Positive Biomarker Results from PROTECT Trial 04-Mar-2026 07:00 RNS
Update on funding and total voting rights 23-Feb-2026 07:51 RNS
Chief Strategy Officer and Board appointments 30-Jan-2026 08:22 RNS
Result of Annual General Meeting 29-Jan-2026 14:13 RNS
Grant of Options under Long Term Incentive Scheme 28-Jan-2026 16:48 RNS
Half Year Trading Update 19-Jan-2026 07:00 RNS
Notice of 2025 Annual General Meeting 06-Jan-2026 07:00 RNS
Results of General Meeting 29-Dec-2025 13:07 RNS
Results of General Meeting 29-Dec-2025 13:07 RNS
Grassmuno® marketing authorisation in Germany 16-Dec-2025 07:00 RNS
Authority for allotment of New Shares 12-Dec-2025 07:00 RNS
Prelim Results and publication of Annual Report 11-Dec-2025 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AGY Market Data

Currency UK Pounds
Share Price 10.00p
Change Today -0.85p
% Change -7.83 %
52 Week High 12.10
52 Week Low 6.60
Volume 255,046
Shares Issued 6,332m
Market Cap £633.25m
Beta 0.00
RiskGrade 268

AGY Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
68.95% below the market average68.95% below the market average68.95% below the market average68.95% below the market average68.95% below the market average
65.85% below the sector average65.85% below the sector average65.85% below the sector average65.85% below the sector average65.85% below the sector average
Price Trend
93.47% above the market average93.47% above the market average93.47% above the market average93.47% above the market average93.47% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income Not Available
Growth
53.41% below the market average53.41% below the market average53.41% below the market average53.41% below the market average53.41% below the market average
79.31% below the sector average79.31% below the sector average79.31% below the sector average79.31% below the sector average79.31% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AGY Dividends

No dividends found

Trades for 11-May-2026

Time Volume / Share Price
16:35 13,000 @ 10.00p
16:35 1 @ 10.00p
16:35 12,999 @ 10.00p
16:03 29,930 @ 10.00p
15:38 920 @ 9.50p

AGY Key Personnel

CEO Manuel Llobet

Top of Page